Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
The American Journal of Physiology
|
January 14, 1999
The metabolic consequences of critical illness: acute effects on glutamine and protein metabolism
N C Jackson, P V Carroll, D L Russell-Jones, et al.
Clinical Endocrinology
|
January 17, 2004
Successful treatment of childhood-onset Cushing's disease is associated with persistent reduction in growth hormone secretion
P V Carroll, J P Monson, A B Grossman, et al.
Clinical Endocrinology
|
April 21, 1999
Recombinant human insulin-like growth factor-I (rhIGF-I) therapy in adults with type 1 diabetes mellitus: effects on IGFs, IGF-binding proteins, glucose levels and insulin treatment
P V Carroll, M Umpleby, E L Alexander, et al.
Diabetes
|
September 1, 1997
rhIGF-I administration reduces insulin requirements, decreases growth hormone secretion, and improves the lipid profile in adults with IDDM
P V Carroll, M Umpleby, G S Ward, et al.
Hormone Research
|
October 10, 2002
Growth in disorders of adrenal hyperfunction
M O Savage, S Scommegna, P V Carroll, et al.
Clinical Endocrinology
|
July 1, 1997
Growth hormone therapy may benefit protein metabolism in mitochondrial encephalomyopathy
P V Carroll, A M Umpleby, E Albany, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 1, 1997
The effect of recombinant human growth hormone on glucose and leucine metabolism in Cushing's syndrome
S B Bowes, M Umpleby, M H Cummings, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 16, 2013
The prevalence and natural history of pituitary hemorrhage in prolactinoma
K N Sarwar, M S B Huda, V Van de Velde, et al.
Diabetes
|
July 25, 2000
IGF-I treatment in adults with type 1 diabetes: effects on glucose and protein metabolism in the fasting state and during a hyperinsulinemic-euglycemic amino acid clamp
P V Carroll, E R Christ, A M Umpleby, et al.
Clinical Endocrinology
|
March 16, 2002
Normal VLDL metabolism despite altered lipoprotein composition in type 1 diabetes mellitus
E R Christ, P V Carroll, E Albany, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
The American Journal of Physiology
|
January 14, 1999
The metabolic consequences of critical illness: acute effects on glutamine and protein metabolism
N C Jackson, P V Carroll, D L Russell-Jones, et al.
Clinical Endocrinology
|
January 17, 2004
Successful treatment of childhood-onset Cushing's disease is associated with persistent reduction in growth hormone secretion
P V Carroll, J P Monson, A B Grossman, et al.
Clinical Endocrinology
|
April 21, 1999
Recombinant human insulin-like growth factor-I (rhIGF-I) therapy in adults with type 1 diabetes mellitus: effects on IGFs, IGF-binding proteins, glucose levels and insulin treatment
P V Carroll, M Umpleby, E L Alexander, et al.
Diabetes
|
September 1, 1997
rhIGF-I administration reduces insulin requirements, decreases growth hormone secretion, and improves the lipid profile in adults with IDDM
P V Carroll, M Umpleby, G S Ward, et al.
Hormone Research
|
October 10, 2002
Growth in disorders of adrenal hyperfunction
M O Savage, S Scommegna, P V Carroll, et al.
Clinical Endocrinology
|
July 1, 1997
Growth hormone therapy may benefit protein metabolism in mitochondrial encephalomyopathy
P V Carroll, A M Umpleby, E Albany, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 1, 1997
The effect of recombinant human growth hormone on glucose and leucine metabolism in Cushing's syndrome
S B Bowes, M Umpleby, M H Cummings, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 16, 2013
The prevalence and natural history of pituitary hemorrhage in prolactinoma
K N Sarwar, M S B Huda, V Van de Velde, et al.
Diabetes
|
July 25, 2000
IGF-I treatment in adults with type 1 diabetes: effects on glucose and protein metabolism in the fasting state and during a hyperinsulinemic-euglycemic amino acid clamp
P V Carroll, E R Christ, A M Umpleby, et al.
Clinical Endocrinology
|
March 16, 2002
Normal VLDL metabolism despite altered lipoprotein composition in type 1 diabetes mellitus
E R Christ, P V Carroll, E Albany, et al.
Page
of 4